RNA SCHEDULE 13G/A: SEC filing

An institutional holder

Filed with the SEC on Aug 14, 2026 · accession 0000080255-26-000590

RNA filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 14, 2026. An institutional holder filed an amended Schedule 13G disclosing its beneficial ownership position in Atrium Therapeutics, Inc. (RNA). The stock moved +4.1% by the first close after the filing.

Summary of the filing

An institutional holder filed an amended Schedule 13G disclosing its beneficial ownership position in Atrium Therapeutics, Inc. (RNA). The filing indicates a passive investment stake with no reported intent to influence control.

For details, click here →

Key details

IssuerAtrium Therapeutics, Inc.

How RNA stock reacted

Close before

$12.33

Aug 13, 2026

First close after

+4.14%

$12.84

5 trading days

+9.33%

$13.48

Since filing

-32.36%

$8.34

✦ Ask GOAX AI about this filing — what it means for RNA, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for RNA?

Click here

Frequently asked questions

What did RNA file with the SEC on Aug 14, 2026?

RNA filed a SCHEDULE 13G/A (SEC filing). An institutional holder filed an amended Schedule 13G disclosing its beneficial ownership position in Atrium Therapeutics, Inc. (RNA). The filing indicates a passive investment stake with no reported intent to influence control.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did RNA stock react to this filing?

RNA closed at $12.33 before the filing and $12.84 on Aug 14, 2026 (+4.14%). Five trading days later: $13.48 (+9.33%).

Other RNA SEC filings

Get alerts when RNA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

RNA overview RNA analysis RNA news Latest SEC filings